Filing Details
- Accession Number:
- 0001209191-23-010595
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-02-17 16:19:19
- Reporting Period:
- 2023-02-06
- Accepted Time:
- 2023-02-17 16:19:19
- Original Submission Date:
- 2023-02-08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831828 | Vera Therapeutics Inc. | VERA | Pharmaceutical Preparations (2834) | 812744449 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861684 | R Joseph Young | C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005 | Svp, Finance, Chief Acct Offcr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-02-06 | 5,714 | $7.00 | 22,679 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person's original Form 4 contained a typographical error on the transaction date.
- Shares purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 6, 2023. The purchase price is the offering price.
- Includes 817 shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022.
Billionaire Hedge Funds
